Pascal Maire

2.4k total citations · 1 hit paper
58 papers, 1.8k citations indexed

About

Pascal Maire is a scholar working on Pharmacology, Epidemiology and Oncology. According to data from OpenAlex, Pascal Maire has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pharmacology, 14 papers in Epidemiology and 11 papers in Oncology. Recurrent topics in Pascal Maire's work include Antibiotics Pharmacokinetics and Efficacy (35 papers), Pneumonia and Respiratory Infections (11 papers) and Drug Transport and Resistance Mechanisms (9 papers). Pascal Maire is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (35 papers), Pneumonia and Respiratory Infections (11 papers) and Drug Transport and Resistance Mechanisms (9 papers). Pascal Maire collaborates with scholars based in France, United States and Mali. Pascal Maire's co-authors include Laurent Bourguignon, Sylvain Goutelle, Xavier Barbaut, Michel Ducher, Florent Rougier, Roger W. Jelliffe, Michel Maurin, Michael Van Guilder, Nathalie Bleyzac and G. Aulagner and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Theoretical Biology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Pascal Maire

57 papers receiving 1.7k citations

Hit Papers

The Hill equation: a review of its capabilities in pharma... 2008 2026 2014 2020 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Maire France 19 576 330 266 196 194 58 1.8k
David Czock Germany 23 435 0.8× 259 0.8× 377 1.4× 255 1.3× 328 1.7× 111 2.3k
David Z. D’Argenio United States 26 384 0.7× 594 1.8× 249 0.9× 180 0.9× 294 1.5× 96 2.3k
Yoshitaka Yano Japan 23 465 0.8× 332 1.0× 214 0.8× 133 0.7× 288 1.5× 83 1.8k
Martin Bergstrand Sweden 17 487 0.8× 311 0.9× 340 1.3× 376 1.9× 315 1.6× 38 2.5k
Sylvain Goutelle France 21 843 1.5× 419 1.3× 529 2.0× 175 0.9× 494 2.5× 111 2.4k
Leo Stolk Netherlands 23 623 1.1× 468 1.4× 202 0.8× 544 2.8× 216 1.1× 68 2.4k
J. Paul Monk United States 27 556 1.0× 643 1.9× 295 1.1× 152 0.8× 132 0.7× 58 3.3k
Ene Ette United States 24 436 0.8× 321 1.0× 200 0.8× 423 2.2× 252 1.3× 68 2.1k
Cees Neef Netherlands 32 476 0.8× 475 1.4× 380 1.4× 477 2.4× 264 1.4× 116 3.1k
DR Mould United States 7 287 0.5× 240 0.7× 158 0.6× 202 1.0× 117 0.6× 7 1.5k

Countries citing papers authored by Pascal Maire

Since Specialization
Citations

This map shows the geographic impact of Pascal Maire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Maire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Maire more than expected).

Fields of papers citing papers by Pascal Maire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Maire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Maire. The network helps show where Pascal Maire may publish in the future.

Co-authorship network of co-authors of Pascal Maire

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Maire. A scholar is included among the top collaborators of Pascal Maire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Maire. Pascal Maire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coulibaly, Brahima, et al.. (2022). Antibiotic therapy for infectious hemodialysed patients in Bamako: Pharmacokinetic analyses and first improvement suggestions. Annales Pharmaceutiques Françaises. 80(6). 810–818. 1 indexed citations
2.
Bourguignon, Laurent, et al.. (2016). Mathematical modeling and systems pharmacology of tuberculosis: Isoniazid as a case study. Journal of Theoretical Biology. 399. 43–52. 6 indexed citations
3.
Bourguignon, Laurent, et al.. (2011). Étude coût-efficacité de l’adaptation bayésienne des posologies des aminosides en gériatrie. Therapies. 66(5). 445–452. 4 indexed citations
4.
Uhart, M., et al.. (2011). Relation entre consommation de benzodiazépines et chutes en gériatrie : étude multicentrique dans trois établissements gériatriques d’un CHU. Annales Pharmaceutiques Françaises. 70(1). 46–52. 6 indexed citations
5.
6.
Bourguignon, Laurent, et al.. (2009). Evaluation of various gentamicin dosage regimens in geriatric patients: a simulation study. Fundamental and Clinical Pharmacology. 24(1). 109–113. 10 indexed citations
7.
Goutelle, Sylvain, Michel Maurin, Florent Rougier, et al.. (2008). The Hill equation: a review of its capabilities in pharmacological modelling. Fundamental and Clinical Pharmacology. 22(6). 633–648. 629 indexed citations breakdown →
8.
Urien, Saı̈k, et al.. (2004). Pharmacokinetic modelling of cefotaxime and desacetylcefotaxime—a population study in 25 elderly patients. European Journal of Clinical Pharmacology. 60(1). 11–16. 13 indexed citations
9.
Martin, Paul J., Nathalie Bleyzac, G Souillet, et al.. (2003). Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors. Bone Marrow Transplantation. 32(8). 777–784. 39 indexed citations
10.
Ducher, Michel, Jean‐Pierre Fauvel, Michel Maurin, et al.. (2003). Sodium intake and blood pressure in healthy individuals. Journal of Hypertension. 21(2). 289–294. 22 indexed citations
11.
Ducher, Michel, et al.. (2001). Renal Elimination of Amikacin and the Aging Process. Clinical Pharmacokinetics. 40(12). 947–953. 15 indexed citations
12.
Bleyzac, Nathalie, et al.. (2001). Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation. European Journal of Clinical Pharmacology. 57(6-7). 499–504. 20 indexed citations
13.
Breilh, Dominique, et al.. (2001). Mixed pharmacokinetic population study and diffusion model to describe ciprofloxacin lung concentrations. Computers in Biology and Medicine. 31(3). 147–155. 9 indexed citations
14.
Bleyzac, Nathalie, G Souillet, Paul J. Martin, et al.. (2001). Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens. Bone Marrow Transplantation. 28(8). 743–751. 113 indexed citations
15.
Bleyzac, Nathalie, Alan V. Boddy, François Doz, et al.. (2001). Comparison of nonlinear mixed-effect and non-parametric expectation maximisation modelling for Bayesian estimation of carboplatin clearance in children. European Journal of Clinical Pharmacology. 57(4). 297–303. 11 indexed citations
16.
17.
Charpiat, B., et al.. (1996). How many patients and blood levels are necessary for population pharmacokinetic analysis?. European Journal of Clinical Pharmacology. 51(3-4). 283–288. 17 indexed citations
18.
Maire, Pascal, et al.. (1996). Dosage Regimens of Antibacterials. Clinical Drug Investigation. 11(4). 229–239. 40 indexed citations
19.
Maire, Pascal, Xavier Barbaut, J.M. Vergnaud, et al.. (1994). Computation of drug concentrations in endocardial vegetations in patients during antibiotic therapy. International Journal of Bio-Medical Computing. 36(1-2). 77–85. 4 indexed citations
20.
Hadj‐Aïssa, Aoumeur, et al.. (1990). Renal Function in the Elderly. ˜The œNephron journals/Nephron journals. 54(4). 364–365. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026